However, the chemical composition of GSH does not allow it to be taken orally for central nervous system diseases because little to none crosses the blood-brain barrier
Calcium ions and oxidative cell injury
Schoenenberger (1986) Delta sleep-inducing peptide in spontaneously hypertensive rats Pharmacology Biochemistry and Behavior, Volume 24, Issue 6, June 1986, Pages 1797-1799
As we continue to explore the potential of BPC-157, it's crucial to maintain high standards in its preparation to ensure reliable and reproducible results in research and potential therapeutic applications
Arthritis Res Ther (2018) 20(1):114

Key Ingredients Glutathione NMN NAD+ Tranexamic Acid Ingredients Water, Glycerin, Niacinamide, Butylene Glyco, Tranexamic Acid, 1,2-Hexanediol, Boron Nitride, Polyglycery!-10 Laurate, Propanediol, Hydroxyacetophenone, Cetyl Ethylhexanoate, Ethylhexyl Palmitate, Squalane, Arginine, Carbomer, Sucrose Distearate, Hydrogenated Lecithin, Caprylic/Capric Triglyceride, Galactomyces Ferment Filtrate, Zea Mays (Com) Kerel Extract, Ethylhexylglycerin, Glutathione, xanthan Gum, Adenosne, risodium Ethylenediamine Disuccinate, Hydrolyzed Gardenia Florida Extract, Hydrolyzed Malt Extract, Hydrolyzed Viola Tricolor Extract, Hydrolyzed Hyaluronic Acid, Hyaluronic Acid, Sodium Hyaluronate, Fructan, Glucose, Disodium EDTA, Nicotinamide Mononucleotide, Dimethysianol Hyaluronate, Hydrolyzed Sodium Hyaluronate, Potassium Hyaluronate, Hydroxypropytrimonium Hyaluronate, Sodium Hyaluronate Crosspolymer, Sodium Hyaluronate Dimethysiano, Sodium Acetylated Hyaluronate, Lactobacillus Ferment Lysate, Cholesterol, Nicotinamide Adenine Dinucleotide Content 30 ml / 1.01 fl oz For Topical and Cosmetic Use Only
